Poster discussion hub abstracts ablation for TRAP sequence, fetal cord blood sampling, fetal blood transfusion, fetal ascites aspiration, thoraco-centesis for severe fetal pleural effusion, amnioinfusion and fetal intramuscular injection for anesthesia. We descriptively analysed the feasibility and efficacy of real-time two-dimensional B-mode bi-plane image using eM6C probe. Results: In all cases, we found the safety because of the real-time two-dimensional images would provide other organ positions such as liver, lung, and heart that we could not see in using 1 dimensional image. In centesis into small cavity such as umbilical cord or thoracic cavity, 3D information supported us the successful centesis by leading tip position. The technical limit is that the well-trained assistant must chase the needle tip by tracking ball just online the guided needle after operator. We needed ''momentary stop '' just before final insertion from the edge of the organ surface. Conclusions: A biplane mode of real-time 4D imaging may be a promising tool for applying fetal interventions.
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Supporting information can be found in the online version of this abstract Objectives: Shortened cervical length (CL) following operative fetoscopy (OF) predisposes to preterm birth. Yet, determinants for cervical change are poorly understood. We hypothesised that clinical and intraoperative factors affect the uterine cervix and aimed to identify the primary cause of cervical change following OF. Methods: Patients referred for OF had preoperative transvaginal sonogram measurement of CL, anterior C angle, C width, CL with valsalva, presence of funnelling, sludge, and moon sign. Measurements were repeated postoperatively and weeks 1 and 2. Preoperative findings and postoperative changes in cervical parameters were related to multiple clinical and operative characteristics excluding women with post OF cerclage or pessary. Results: 92 OF were performed at a median gestation of 19.8 weeks (12.7-32.7). CL increased in 34 (59.6%) by 48 hours after OF remaining stable over the following 2 weeks. Funnelling was the only qualitative parameter that significantly decreased (p=0.03). Magnitude of decrease in CL after OF was related to the preoperative CL, laser energy, and amnioinfusion (r 2 0.43, p=0.03) and further predicted by the degree of preoperative CL shortening with valsalva (r 2 0.38, p<0.001). 11/13 women with preoperative CL <25mm retained a short cervix after OF (p<0.001). Postoperative CL <25mm was only predicted by a short preoperative cervix with a 95% sensitivity and 94% specificity (CL <29mm, ROC AUC 0.95, 0.88-1, p<0.001). Conclusions: Changes in cervical dynamics after OF are largely independent of multiple intraoperative factors. Despite significant intrauterine manipulation, post-surgical cervical changes are determined by preoperative cervical status, likely due to underlying disease. Cervical dynamics improve in most cases however women with a preoperative CL < 29mm require reassessment for potential cervical intervention on postoperative days 1 and 2.
Supporting information can be found in the online version of this abstract Objectives: The aim of the study was to assess the effects of embryo reduction (ER) in trichorionic triplet pregnancies on the gestational age (GA) at delivery and the intertwin birthweight (BW) discordance. Methods: This was a retrospective cohort study. ER was performed before 16 weeks' gestation in all pregnancies via the transabdominal approach. Dichorionic, as well as monochorionic, triplets and triplet pregnancies reduced to one embryo were excluded from analysis. We compared the GA at delivery and the prevalence of intertwin BW discordance greater than 20% in trichorionic triplet pregnancies reduced to twins with primary dichorionic twins. Results: We identified 52 reduced trichorionic triplet pregnancies which underwent ER and 226 primary dichorionic twin pregnancies. The procedure-related fetal loss rate was 1.9%. Reduced twin pregnancies had significantly lower GA at delivery than the primary twins (median 34.0, IQR 31. There were no significant difference between reduced and primary dichorionic twins regarding BW discordance >20% (15.3% vs. 18.1%, respectively P=0.61). Conclusions: Embryo reduction is not associated with increased incidence of BW discordance, but is associated with delivery on an average 2-3 weeks earlier when compared to the primary dichorionic twins.
P16: SCREENING FOR FETAL ANOMALIES
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The value of prenatal chromosomal microarray analysis in fetuses with structural ultrasound abnormalities and a normal karyotype in China
Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China
Objectives: The aim of this study was to evaluate the contribution of chromosomal microarray analysis (CMA) in the prenatal diagnosis of fetuses with structural anomalies but normal chromosomal karyotype. Methods: Fetuses with structural anomalies underwent chromosome conventional G-banding karyotyping. Fetuses with normal karyotype were performed on CMA including the array-based comparative genomic hybridisation (aCGH) and array-single-nucleotide polymorphism (SNP). Results: Out of the 402 pregnancies with structural ultrasound abnormalities, karyotyping revealed a chromosomal abnormality in 33 (8.2%). Among fetuses with structural ultrasound abnormalities and normal karyotype(n=369) that underwent CMA, the detection rate of copy number variants (CNV) was 22.2% (82/369), including pathogenic CNV in 11.4% (42/369) and variants of uncertain clinical significance (VOUS) in 10.8% (40/369). In the groups of cardiac, central nervous, musculoskeletal, facial and urogenital malformations, the rate of the pathogenic CNV were 16.6% (38/229), 21.9% (14/64), 15.5% (15/97), 13.5% (7/52) and 18.8% (6/32) respectively. Ultrasound anomaly restricted to one anatomical system (n=238) had a 10.5% (n=25) chance of carrying a pathogenic CNV, while this chance increased to 13.0% (n=17) for multiple ultrasound anomalies (n=131). Conclusions: In the assessment of genetic abnormalities in pregnancies with fetal anomalies, the diagnostic yield may be increased by 22% if CMA is used as a complementary tool to conventional cytogenetics. Our results suggest that CMA is valuable in prenatal genetic diagnosis of fetuses with fetal anomalies.
Supporting information can be found in the online version of this abstract Objectives: Circulating fetal cells from the maternal blood possess the potential to be applied as candidates in a non-invasive prenatal test (cbNIPT). Fetal cells have an advantage over cell free fetal DNA (cffDNA) in that the complete fetal genome is neither degraded nor it is contaminated with maternal DNA. Thus, it should be more accessible for chromosomal and subchromosomal analysis. We present a method for enriching fetal trophoblast cells from maternal blood, subsequent amplification of the fetal genome, and detection of chromosomal variations in the genome. Methods: Blood samples were collected in gestational week 10 to 13. Fetal trophoblast cells were enriched and stained using fetal cell specific antibodies. The enriched cell fraction was scanned, and for samples coming from high risk pregnancies, positively detected fetal cells were picked using a capillary based cell picking instrument. Subsequent whole genome amplification was performed on fetal cells and the DNA was analysed by array CGH. Results: From 190 pregnancies, an average of 12.8 (range 1-46) fetal trophoblast cells were recovered from 30 ml of maternal blood. From high risk pregnancy samples, fetal cells were picked and whole genome amplification was performed which resulted in DNA in quantity and quality high enough to generate array CGH profiles. We present a range of cases comparing our non-invasive cell based prenatal test results with CVS array CGH results. These includes aneuploidies, both full and mosaics, and sub-chromosomal cases, for e.g. an unbalanced translocation t(4;8) resulting in a 31 Mb deletion and a 30 Mb duplication, and a partial Trisomy 21 with a 12.4 Mb duplication of chromosome 21.
Conclusions:
Results from the genome analyses on fetal trophoblast cells enriched from maternal blood were verified by array CGH on CVS samples. Chromosomal and sub-chromosomal analyses can be performed on fetal cells enriched from maternal blood.
The developed method has the future potential of being offered as a cell-based NIPT with large genomic coverage. Objectives: Epigenetic mechanisms might play a role in Down's syndrome (DS), which is the most common aneuploidy in man.
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In our previous work, we studied miRNA expressions in normal and trisomic placentas. We have found seven miRNAs significantly upregulated in DS placentas. We would expect, according to biological functions of miRNA, that similar findings could be present in maternal plasma of affected pregnancies. Methods: A total of 26 plasma samples from pregnant women -13 bearing DS fetuses and 13 normal karyotype fetuses, were included. Genome-wide miRNA expressions were profiled using Affymetrix miRNA 4.1 array strips. Results were evaluated using Partek Genomics Suite. The one-way ANOVA with a cut-off p-value < 0.05 and Benjamini-Hochberg correction for multiple testing was used for detection of differentially expressed miRNAs.
Results:
We identified 61 human miRNAs as being significantly dysregulated between compared groups of samples. Unlike the placenta, most of these miRNAs (44) were down-regulated in plasma of women bearing the DS fetus. Many biological pathways were identified as being potentially influenced by altered miRNA levels. Cell communication and signalling pathways were between the most enriched ones. Seven miRNAs, previously determined as upregulated in DS placentas, did not differ on the plasma level. Conclusions: Our study shows that differences of miRNA profiles between normal and DS fetuses are detectable even on the level of maternal plasma. Such differences could mirror alterations in placental development and they deserve further study. 
